Professor George KK Lau is currently the Chairman of Humanity and Health Medical Center, Hong Kong and Chair Professor and Director of 302 Beijing - Humanity and Health Hepatitis C Clinic, Beijing. He has a distinguished career in the conduct of translational research in the field of chronic HBV and HCV infection. He has pioneered work in adoptive clearance of HBV infection and the use of pre-emptive lamivudine to prevent HBV reactivation after chemotherapy. Professor Lau’s major research interests involved conduct of translational research and clinical trials in Hepatology. He has more than 500 publications with citations of over 10,000.